期刊文献+

^(99m)Tc-MIBI显像预测非小细胞肺癌化疗疗效的应用研究 被引量:5

下载PDF
导出
摘要 目的 探讨99mTc -MIBI肺显像在预测非小细胞癌化疗疗效的价值。方法  36例肺癌患者静脉注射99mTc -MIBI 74 0~ 1110MBq后 2 0min及 2~ 3h分别行早期及延迟显像 ,计算摄取比值T/Ne、T/Nd和清除指数E值。分析化疗有效组与化疗无效组T/Ne、T/Nd和E值之间的区别。结果 两组间的早期摄取比值T/Ne及清除指数E值差异有统计学意义 (P <0 0 5 ) ,T/Nd两组间差异无统计学意义 (P >0 0 5 )。T/N比值及E值与组织学类型之间无明显关系 (P >0 0 5 )。结论 99mTc -MIBI肺肿瘤显像在预测肺癌化疗疗效、为临床制定合适的化疗方案方面具有重要的临床价值。
出处 《广东医学》 CAS CSCD 北大核心 2005年第1期67-68,共2页 Guangdong Medical Journal
基金 广东省医学科学技术研究基金立项项目 (编号 :A2 0 0 0 0 89)
  • 相关文献

参考文献4

  • 1孙燕 周际昌.临床肿瘤内科手册(第3版)[M].北京:人民卫生出版社,1996.98.
  • 2Sugawara I, Yamada H, Nakaraura H, et al. Prefernatial expression of the multidrug resistance - assodated protein (MRP) in adenocarcinoma of the lung. Int J Cancer,1995, 64(5): 323.
  • 3Koukourakis M, Klukonraki S, Giatromanolaki A, et al, Non - small cell lung cancer functional imaging: incrmased hexakis - 2 - nzthoxy-isobutyl- isonitrile tumor clearance correlates with resistance to cytotoxic. Clinical Cancer Research, 1997, 3(5): 749.
  • 4韩宝惠,廖美琳,王帏雯,周箴,谢文辉,曾峻.^(99)mTc-MIBI 核素显像对预测肺癌化疗疗效的探讨[J].中国肺癌杂志,2000,3(3):224-225. 被引量:3

二级参考文献7

  • 11,DeuchaersK,LingV.P-glycoproteinandmultidrugresistanceincancerchemotherapy.SeminOnocl,1989,16(2)∶156-165.
  • 22,BroxtermanHJ,LankemaJ,PinedoHM.HowtoprobeclinicaltumorsamplesforP-glycoproteinandmultidrugresistance-associatedprotein.EurJCancer,1996,32(12)∶1024-1033.
  • 33,MuellerS,GAUTH-TougelidesB,CreutzigH.Imagingofmalignanttumorswith99mTc-sestamibi.JNuclMed,1987,28(6)∶562.
  • 44,SugawaraI,YamadaH,NakamuraH,etal.Preferentialexpressionofthemultidrugresistance-associatedprotein(MRP)inadenocarcinomaofthelung.IntJCancer,1995,64(5)∶323-325.
  • 55,OtaE,AbeY,OshikaY,etal.Expressionofthemultidrugresistanceassociateprotein(PRP)geneinnon-smallcelllungcancer.BrJCancer,1995,72(5)∶550-540.
  • 66,KoukourakisM,KoukourakiS,GiatromanolakiA,etal.Non-smallcelllungcancerfunctionalimaging:increasedhexakis-2-methoxy-isobutyl-isonitriletumorclearancecorrelateswithresistancetocytotoxictreatment.ClinicalCancerResearch,1997,3(5)∶749-754.
  • 77,NakamuraM,OtaM,OzekiY,etal.Expressionofthemultidrugresistance(MDRI)innon-smallcelllungcancer.JpnJCancer,1994,9(4)∶538-541. (收稿:1999-11-23修回:2000-03-07)

共引文献170

同被引文献37

  • 1关晏星,杨晓青,朱传明,张青,张庆,武彪,欧阳军,雷秋模,翟伟,熊秋云,吴晓波,王莉,曹亚丽,熊立跃.^(99)Tc^m—MIBI显像评价乳腺癌新辅助化疗疗效[J].中华核医学杂志,2006,26(1):36-38. 被引量:10
  • 2薛建军,杨爱民,张芬茹,王鸿雁,邓元,李积厚,冯新利.原发性肺癌摄取^(99)Tc^m-MIBI与耐多药蛋白表达的关系[J].中国医学影像技术,2006,22(7):1090-1094. 被引量:8
  • 3叶千春,王淑侠,乔穗宪,唐安戊,何建军.^(99)Tc^m-MIBI甲状腺显像鉴别甲状腺结节良恶性再认识[J].中华核医学杂志,2006,26(4):209-210. 被引量:16
  • 4廖斌,卢炜.两种散瞳剂在弱视儿童验光中的应用探讨[J].国际眼科杂志,2007,7(3):868-869. 被引量:11
  • 5Lumachi F, Ferretti G, Povolato M, et al. Usefulness of 99m-Tcsestamibi scintimammography in suspected breast cancer and in axillary lymph node metastases detection [J]. EurJ Surg Oncol, 2001, 27 (3) :256-259.
  • 6Pauwels O, Gozy M, Van Houtte P, et al. Cross resistance and collateral sensitivity between cytotoxic drugs and radiation in two human bladder cell lines [J]. Radiother Oncol, 1996,39( 1 ) :81-86.
  • 7Yuksel M, Cennik TF, Doganay L, et al. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis [J]. Eur J Nuel Med Mol Imaging, 2002,29(7) :876-881.
  • 8Hsu WH, Yen RF, Kao CH, et al. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer (stage Ⅲ b or Ⅳ) with a higher T stage ( > T2). Technetium-99m methoxyisobutylisonitrile chest single photon emission computed tomography and P-glycoprotein express ion [ J]. Oncology, 2002,63 (2) : 173-179.
  • 9Nishiyama Y, Yamamoto Y, Fukunaga K, et al. Evaluation of radiotherapeutic response in non-small cell lung cancer patients by technetium-99m MIBT and thallium-201 chloride SPET [ J]. Eur J Nucl Med, 2000,27 (5) :536-541.
  • 10Yuksel M, Cermik TF, Doganay L, et al. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis [J]. Eur J Nucl Med Mol Imaging, 2002,29(7) :876-881.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部